Hematologic toxicity was assessed by measuring WBC, RBC, and platelet counts twice weekly in the Raji-xenografted mice that were treated as described in Figure 2.

When compared with RIT alone, there was no difference in hematologic toxicity in the CMIT groups. In addition, no hematologic toxicity was observed in the mice treated with HB22.7 alone.